Category Archives: Events

Latest From Events

Session Recap: Digital Health—Early Successes for Investors and Biotech R&D Productivity

shutterstock_27160801

Digital health has the potential to improve the life science industry by combining traditional and novel medicines with digital technologies, enabling the life sciences to become more patient-centered as well as accelerating product discovery. There is growing interest in digital health among investors as new data and technologies become available that fill unmet needs in the marketplace. At the 17th Annual BIO CEO & Investor Conference, a panel of digital health experts came together to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Producing “21st Century Cures” – 2015 U.S. Legislative Outlook with Chairman Upton and Rep. DeGette

21st-Century-Cures--Free

BIO President & CEO Jim Greenwood today sat down with Energy & Commerce Committee Chairman Fred Upton (R-MI) and Congresswoman Diana DeGette (D-CO) for a lively and in-depth discussion of the 21st Century Cures Initiative, a comprehensive effort to accelerate the discovery, development and delivery of new drugs and therapies. The conversation was a great way to kick off the opening plenary of the 17th BIO CEO & Investor Conference. This year’s conference, as Greenwood noted, has a Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO CEO & Investor Conference Kicks Off in NYC

CEO2013_115x75_Thumbnail copy

The 17th Annual BIO CEO & Investor Conference opened today with a record number of partnering meetings and company presentations, in addition to key policy, business, and science panels highlighting the biotech issues of the day. During the Welcome & Opening Plenary session, BIO President & CEO Jim Greenwood spoke with Energy & Commerce Committee Chairman Fred Upton (R-MI) and Congresswoman Diana DeGette (D-CO) about the 21st Century Cures Initiative, a comprehensive effort to accelerate the discovery, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Getting Ahead of Ebola and Other Infectious Threats—Overturning Assumptions

ebola

Ebola was one of the biggest stories of 2014 (with Ebola fighters named the TIME Person of the Year), and the epidemic has led to renewed interest from governments and philanthropies to tackle the problem of emerging infectious diseases. To discuss the lessons learned and new approaches being taken in light of the Ebola crisis, BIO hosted a panel today at the 17th Annual BIO CEO & Investor Conference here in New York, moderated by Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Patients Remain the Focus for the Future of Personalizing Oncology

lab_tech02

The 17th Annual BIO CEO & Investor Conference, being held at the Waldorf Astoria in New York City, kicked off this morning with an interactive panel of industry heavyweights discussing the growing trend to personalize oncology treatments with molecular diagnostics. Moderated by Michael King, Managing Director, Senior Research Analyst, JMP Securities. Michael helped steer the group of experts as they discussed enabling broader matching of patient-cancer-therapy, lessons learned from the Cancer Genome Atlas and the potential Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,